News Releases
50 Stories Found

Oral Health Linked to Head and Neck Cancer Risk and Survival

Moffitt Receives $3 Million to Develop New Targeted Treatments for Rare Melanomas

Moffitt Cancer Center Recognized on Forbes’ America’s Best-in-State Employers 2023 List

Moffitt Awarded $5.5 Million to Study Virus-Associated Tumors Among Those Living with HIV in Sub-Saharan Africa

Moffitt Researchers Use Mathematical Modeling and Dynamic Biomarkers to Characterize Metastatic Disease During Adaptive Therapy

FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma

Moffitt Cancer Center Recognized on Forbes’ Best Employers for Women 2023 List

Moffitt Names Paulo Rodriguez, Ph.D., Chair of the Department of Immunology and Co-Leader of the Immuno-Oncology Program

Moffitt Cancer Center a Best and Brightest Company to Work For in the Nation for the 7th Year in a Row

Moffitt Cancer Center Celebrates Grand Opening of Moffitt McKinley Hospital

Breast Cancer Survivors Experience Faster Biological Aging Compared to Cancer-Free Women

Moffitt Cancer Center at Port Tampa Bay Offers Community Outreach and Education

Brian D. Gonzalez, Ph.D., Named Inaugural Associate Center Director of Research Diversity and Workforce Development

Moffitt Investigates Association between Inflammation and Treatment Related Symptoms in Gynecologic Cancers

Moffitt Cancer Center Named Top 10 in Nation by Newsweek